About MaraTech USA

Building Treatment-Response and Continuity Infrastructure in the United States.

We are focused on the operational space between an early biological signal, clinician review, and a completed next step.

Our mission

Help specialty practices create timely, traceable, clinician-directed continuity around treatment response—beginning with osteoporosis care.

Why osteoporosis first

Long treatment cycles, varied follow-up workflows, and existing bone turnover marker use create a practical setting in which to validate the operating model.

Built from deep technical experience

MaraTech USA builds on scientific and technology capabilities developed through MARA Nanotech. Specific technology and commercialization rights will be governed by definitive agreements.

FOUNDER

Dr. HeaYeon Lee brings more than 30 years of work across nanotechnology, biosensing, research translation, and healthcare innovation.

View Dr. HeaYeon Lee's CV →

How we work

Start with a narrow operational problem
Fit into the practice's existing workflow
Keep clinicians in control
Measure what happens after the result
Expand only after validation

Based in New York and initially working across the New York–New Jersey healthcare ecosystem.

Start with your current workflow

Let’s begin with one workflow.

We welcome introductions to practice leaders and strategic collaborators.

Connect With Us